Facebook
X
LinkedIn
ForwardNitrous Oxide Administration Training Course 2025-2026
About the Course
This two-day course is designed to enhance healthcare providers’ understanding of the pharmacology, clinical effects, and applications of nitrous oxide in pediatric procedural sedation. Through interactive scenarios and observation of nitrous oxide administration during patient care, learners will gain insight into its appropriate and safe use. The course provides essential knowledge and core competencies to support effective sedation practices in children. It is tailored to meet the needs of experienced sedation providers seeking both didactic and simulation-based education and training.
Elements of Competence
This activity has been designed to change learner competence and focuses on the following competencies:
American Board of Medical Specialties:
- Patient care and procedural skills
- Medical knowledge
- Practice-based learning and improvement
- Provide patient/person-centered care
- Employ evidence-based practice
Interprofessional:
- Roles and responsibilities
- Communication
- Teams and Teamwork
Intended Audience
This activity is designed to meet the educational needs of physicians, physician assistants, nurses, and advanced practice nurses.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will be able to:
- Evaluate the pharmacology and clinical applications of nitrous oxide, including its advantages, disadvantages, efficacy, and potential adverse events.
- Identify the role of nitrous oxide in pediatric sedation.
- Explain the function and components of the delivery system used for nitrous oxide administration.
- Demonstrate proficiency in administering and monitoring nitrous oxide through hands-on practice with inhalation equipment in a clinical setting.
Presenter
Juan P. Boriosi, MD
Associate Professor
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health
Planners
Juan Boriosi, MD
Hanna Drake, RN
Tricia Smith, NP
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name | Role | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
Juan Boriosi | Committee Chair/Speaker | No relevant relationships with ineligible companies to disclose | No |
| Hanna Drake | Planner | No relevant relationships with ineligible companies to disclose | No |
| Tricia Smith | Planner | No relevant relationships with ineligible companies to disclose | No |
Accreditation Statement | |
 | In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements | |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
American Board of Pediatrics (ABP) Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 7.25 MOC points in the American Board of American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. Participant completion information will be shared with the ABP through PARS. By recording your attendance at this event, you are giving UW-ICEP permission to share this information with ABP. | |
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.25 ANCC contact hours. ANCC pharmacotherapeutic hours will be calculated and awarded as appropriate. | |
 | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.725 CEUs or 7.25 hours. | |